STOCK TITAN

MetLife, Inc. 10-Q Filings

MET NYSE

Every 10-Q that MetLife, Inc. (MET) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow MET and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full MET filings page.

Rhea-AI Summary

MetLife, Inc. reported consolidated revenues of $38,228 million and net income of $1,941 million for the six months ended June 30, 2026, with diluted EPS of $2.83, compared with $2.32 a year earlier. Total assets were $759,372 million and total equity was $27,741 million at June 30, 2026.

Total consolidated adjusted earnings were $3,235 million for the first half, led by Group Benefits ($942 million), Asia ($907 million) and RIS ($828 million). The company highlighted a strategic reorganization that elevated MetLife Investment Management to a reportable segment and completed the PineBridge Investments acquisition for $885 million. A pending sale of MetLife Ukraine resulted in a $65 million impairment loss, net of income tax, recorded in net investment gains (losses). Operating cash flow was $4,915 million, and policyholder account balances were $245,458 million.

Rhea-AI Summary

MetLife reported solid Q1 2026 results with higher earnings and stable balance sheet strength. Total revenues were $19,074 million, up from $18,569 million a year earlier, driven by premiums of $12,120 million and net investment income of $5,355 million.

Net income attributable to MetLife, Inc. was $1,185 million versus $945 million, with net income available to common shareholders of $1,140 million compared to $879 million. Basic earnings per common share rose to $1.75 from $1.29, and diluted EPS increased to $1.74 from $1.28.

Total consolidated adjusted earnings across segments reached $1,631 million, up from $1,415 million, with particularly strong contributions from Asia, Group Benefits and RIS. Operating cash flow was $2,687 million, while MetLife returned capital through $372 million of common dividends and treasury stock repurchases of $762 million. The company ended the quarter with total assets of $743,211 million and total equity of $27,595 million, and continued integrating its Strategic Reorganization and the PineBridge Investments acquisition within the MIM segment.

Rhea-AI Summary

MetLife, Inc. reports mixed results for the quarter and nine months ended September 30, 2025. Total revenues for the quarter were $17.4 billion, down from $18.4 billion a year earlier, and net income fell to $902 million from $1.34 billion. Diluted EPS for common shareholders declined to $1.22 from $1.81.

For the first nine months of 2025, revenues were $53.3 billion versus $52.3 billion, but net income decreased to $2.59 billion from $3.17 billion, reflecting weaker investment and derivative results. By contrast, consolidated adjusted earnings rose to $1.65 billion in the quarter from $1.44 billion, with strong contributions from Asia and Group Benefits.

Operating cash flow remained robust at $10.0 billion for the nine months. The company continued returning capital, repurchasing $2.42 billion of common stock and redeeming $988 million of preferred stock, while total assets grew to $719.7 billion and equity to $29.2 billion.